ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 57 filers reported holding ONCOCYTE CORP in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $472,000 | -50.9% | 189,600 | -22.1% | 0.22% | -51.8% |
| Q1 2019 | $961,000 | +92.2% | 243,400 | +189.9% | 0.46% | +109.2% |
| Q1 2017 | $500,000 | -15.5% | 83,958 | 0.0% | 0.22% | -24.8% |
| Q4 2016 | $592,000 | +107.0% | 83,958 | +47.8% | 0.29% | +154.4% |
| Q3 2016 | $286,000 | +17.2% | 56,800 | -17.1% | 0.11% | +5.6% |
| Q2 2016 | $244,000 | -14.4% | 68,495 | +10.8% | 0.11% | +6.9% |
| Q1 2016 | $285,000 | – | 61,817 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |